The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas

Eleni Benson, Ryan Li, David Eisele, Carole Fakhry

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

Human papillomavirus (HPV) is etiologically responsible for a distinct subset of head and neck squamous cell cancers (HNSCCs). HPV-positive HNSCCs (HPV-HNSCCs) most commonly arise from the oropharynx and are responsible for the increasing incidence of oropharyngeal SCC (OSCC) in the United States (US) and abroad. HPV-positive OSCC (HPV-OSCC) has a unique demographic and risk factor profile and tumor biology. HPV-OSCC patients tend to be white, younger, and have a higher cumulative exposure to sexual behaviors as compared with HPV-negative OSCC patients. HPV-positive tumor status also significantly improves survival, and is indeed the single strongest prognostic factor for OSCC. The mechanisms that underlie the improved prognosis conferred by HPV-positive disease are unknown. The purpose of this review is to describe the clinical impact of HPV status in HNSCC, particularly in OSCC, both in terms of the unique clinic-demographic profile and prognostic implications.

Original languageEnglish (US)
Pages (from-to)565-574
Number of pages10
JournalOral Oncology
Volume50
Issue number6
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Squamous Cell Neoplasms
Neoplasms
Head and Neck Neoplasms
Head
Demography
Oropharynx
Carcinoma, squamous cell of head and neck
Sexual Behavior
Survival
Incidence

Keywords

  • Head and neck cancer
  • HPV
  • Oropharyngeal neoplasms
  • Prognosis
  • Risk factors

ASJC Scopus subject areas

  • Oncology
  • Oral Surgery
  • Cancer Research
  • Medicine(all)

Cite this

The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. / Benson, Eleni; Li, Ryan; Eisele, David; Fakhry, Carole.

In: Oral Oncology, Vol. 50, No. 6, 2014, p. 565-574.

Research output: Contribution to journalArticle

Benson, Eleni ; Li, Ryan ; Eisele, David ; Fakhry, Carole. / The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. In: Oral Oncology. 2014 ; Vol. 50, No. 6. pp. 565-574.
@article{1ed8b45648f14b2dbf04e24ac5eeff2e,
title = "The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas",
abstract = "Human papillomavirus (HPV) is etiologically responsible for a distinct subset of head and neck squamous cell cancers (HNSCCs). HPV-positive HNSCCs (HPV-HNSCCs) most commonly arise from the oropharynx and are responsible for the increasing incidence of oropharyngeal SCC (OSCC) in the United States (US) and abroad. HPV-positive OSCC (HPV-OSCC) has a unique demographic and risk factor profile and tumor biology. HPV-OSCC patients tend to be white, younger, and have a higher cumulative exposure to sexual behaviors as compared with HPV-negative OSCC patients. HPV-positive tumor status also significantly improves survival, and is indeed the single strongest prognostic factor for OSCC. The mechanisms that underlie the improved prognosis conferred by HPV-positive disease are unknown. The purpose of this review is to describe the clinical impact of HPV status in HNSCC, particularly in OSCC, both in terms of the unique clinic-demographic profile and prognostic implications.",
keywords = "Head and neck cancer, HPV, Oropharyngeal neoplasms, Prognosis, Risk factors",
author = "Eleni Benson and Ryan Li and David Eisele and Carole Fakhry",
year = "2014",
doi = "10.1016/j.oraloncology.2013.09.008",
language = "English (US)",
volume = "50",
pages = "565--574",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas

AU - Benson, Eleni

AU - Li, Ryan

AU - Eisele, David

AU - Fakhry, Carole

PY - 2014

Y1 - 2014

N2 - Human papillomavirus (HPV) is etiologically responsible for a distinct subset of head and neck squamous cell cancers (HNSCCs). HPV-positive HNSCCs (HPV-HNSCCs) most commonly arise from the oropharynx and are responsible for the increasing incidence of oropharyngeal SCC (OSCC) in the United States (US) and abroad. HPV-positive OSCC (HPV-OSCC) has a unique demographic and risk factor profile and tumor biology. HPV-OSCC patients tend to be white, younger, and have a higher cumulative exposure to sexual behaviors as compared with HPV-negative OSCC patients. HPV-positive tumor status also significantly improves survival, and is indeed the single strongest prognostic factor for OSCC. The mechanisms that underlie the improved prognosis conferred by HPV-positive disease are unknown. The purpose of this review is to describe the clinical impact of HPV status in HNSCC, particularly in OSCC, both in terms of the unique clinic-demographic profile and prognostic implications.

AB - Human papillomavirus (HPV) is etiologically responsible for a distinct subset of head and neck squamous cell cancers (HNSCCs). HPV-positive HNSCCs (HPV-HNSCCs) most commonly arise from the oropharynx and are responsible for the increasing incidence of oropharyngeal SCC (OSCC) in the United States (US) and abroad. HPV-positive OSCC (HPV-OSCC) has a unique demographic and risk factor profile and tumor biology. HPV-OSCC patients tend to be white, younger, and have a higher cumulative exposure to sexual behaviors as compared with HPV-negative OSCC patients. HPV-positive tumor status also significantly improves survival, and is indeed the single strongest prognostic factor for OSCC. The mechanisms that underlie the improved prognosis conferred by HPV-positive disease are unknown. The purpose of this review is to describe the clinical impact of HPV status in HNSCC, particularly in OSCC, both in terms of the unique clinic-demographic profile and prognostic implications.

KW - Head and neck cancer

KW - HPV

KW - Oropharyngeal neoplasms

KW - Prognosis

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=84900489886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900489886&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2013.09.008

DO - 10.1016/j.oraloncology.2013.09.008

M3 - Article

VL - 50

SP - 565

EP - 574

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

IS - 6

ER -